JP2012516890A5 - - Google Patents

Download PDF

Info

Publication number
JP2012516890A5
JP2012516890A5 JP2011549157A JP2011549157A JP2012516890A5 JP 2012516890 A5 JP2012516890 A5 JP 2012516890A5 JP 2011549157 A JP2011549157 A JP 2011549157A JP 2011549157 A JP2011549157 A JP 2011549157A JP 2012516890 A5 JP2012516890 A5 JP 2012516890A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
ring
phenyl
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011549157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012516890A (ja
JP5659166B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/000307 external-priority patent/WO2010090737A1/en
Publication of JP2012516890A publication Critical patent/JP2012516890A/ja
Publication of JP2012516890A5 publication Critical patent/JP2012516890A5/ja
Application granted granted Critical
Publication of JP5659166B2 publication Critical patent/JP5659166B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011549157A 2009-02-05 2010-02-04 ピリダジノン化合物 Active JP5659166B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20220709P 2009-02-05 2009-02-05
US61/202,207 2009-02-05
US21392709P 2009-07-30 2009-07-30
US61/213,927 2009-07-30
PCT/US2010/000307 WO2010090737A1 (en) 2009-02-05 2010-02-04 Pyridazinone compounds

Publications (3)

Publication Number Publication Date
JP2012516890A JP2012516890A (ja) 2012-07-26
JP2012516890A5 true JP2012516890A5 (enExample) 2013-03-14
JP5659166B2 JP5659166B2 (ja) 2015-01-28

Family

ID=42398214

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011549157A Active JP5659166B2 (ja) 2009-02-05 2010-02-04 ピリダジノン化合物

Country Status (37)

Country Link
US (7) US8916566B2 (enExample)
EP (2) EP3006031A1 (enExample)
JP (1) JP5659166B2 (enExample)
KR (1) KR101730665B1 (enExample)
CN (1) CN102365020B (enExample)
AR (1) AR075238A1 (enExample)
AU (1) AU2010211050B2 (enExample)
BR (1) BRPI1008498B8 (enExample)
CA (1) CA2751565C (enExample)
CO (1) CO6410258A2 (enExample)
CR (1) CR20110440A (enExample)
DK (1) DK2393360T3 (enExample)
DO (1) DOP2011000254A (enExample)
EA (1) EA020690B1 (enExample)
EC (1) ECSP11011305A (enExample)
ES (1) ES2561181T3 (enExample)
GE (1) GEP20146004B (enExample)
HR (1) HRP20160065T1 (enExample)
HU (1) HUE027478T2 (enExample)
IL (1) IL214137A (enExample)
JO (1) JO3114B1 (enExample)
MA (1) MA33072B1 (enExample)
ME (1) ME02337B (enExample)
MX (1) MX2011008305A (enExample)
MY (1) MY170610A (enExample)
NZ (1) NZ594851A (enExample)
PE (1) PE20110991A1 (enExample)
PL (1) PL2393360T3 (enExample)
RS (1) RS54504B1 (enExample)
SG (1) SG173175A1 (enExample)
SI (1) SI2393360T1 (enExample)
SM (1) SMT201600008B (enExample)
TN (1) TN2011000362A1 (enExample)
TW (1) TWI457333B (enExample)
UY (1) UY32417A (enExample)
WO (1) WO2010090737A1 (enExample)
ZA (1) ZA201106074B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009054791A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
BRPI1008498B8 (pt) 2009-02-05 2021-05-25 Takeda Pharmaceuticals Co compostos de piridazinona úteis como inibidores da fosfodiesterase 10a, composição farmacêutica, e, uso de um composto
AU2011270994B2 (en) 2010-06-24 2015-12-10 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
EP2593107A1 (en) * 2010-07-12 2013-05-22 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
WO2012018909A1 (en) 2010-08-04 2012-02-09 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds
WO2012018058A1 (ja) 2010-08-04 2012-02-09 武田薬品工業株式会社 縮合複素環化合物
US9090586B2 (en) 2010-08-04 2015-07-28 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP2604597B1 (en) * 2010-08-10 2017-01-04 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof inhibitor of phosphodiesterase 10a
JP2013234123A (ja) * 2010-09-03 2013-11-21 Taisho Pharmaceutical Co Ltd 3−ピラゾリル−2−ピリドン誘導体
CA2827724A1 (en) 2011-02-18 2012-08-23 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
JP5973990B2 (ja) 2011-03-16 2016-08-23 武田薬品工業株式会社 縮合複素環化合物
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
JP6153513B2 (ja) * 2011-08-22 2017-06-28 武田薬品工業株式会社 哺乳類中のホスホジエステラーゼ(pde10a)を定量的に画像化する放射性トレーサとしての放射標識された化合物及びその用途
JP6169492B2 (ja) 2011-11-15 2017-07-26 武田薬品工業株式会社 ジヒドロキシ芳香族へテロ環化合物
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
US10174004B2 (en) * 2013-02-21 2019-01-08 Takeda Pharmaceutical Company Limited Production method of pyridazinone compounds
US9464076B2 (en) 2013-03-15 2016-10-11 Daiichi Sankyo Company, Limited Benzothiophene derivative
US10039764B2 (en) 2013-07-12 2018-08-07 University Of South Alabama Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expression
JP6448647B2 (ja) 2013-09-12 2019-01-09 アリオス バイオファーマ インク. アザ−ピリドン化合物およびその用途
KR102286860B1 (ko) * 2013-09-12 2021-08-05 얀센 바이오파마, 인코퍼레이트. 피리다지논 화합물 및 이의 용도
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
ES2544869B2 (es) * 2014-03-04 2016-01-18 Universidade De Vigo Derivados de piridazin-3(2H)-ona inhibidores selectivos de la isoforma B de la monoaminooxidasa
WO2015141662A1 (ja) 2014-03-18 2015-09-24 武田薬品工業株式会社 固体分散体
KR102373700B1 (ko) 2014-04-02 2022-03-11 인터뮨, 인크. 항섬유성 피리디논
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
MX383931B (es) 2015-03-11 2025-03-14 Janssen Biopharma Inc Compuestos de aza-piridona y usos de estos.
WO2016191935A1 (en) * 2015-05-29 2016-12-08 Merck Sharp & Dohme Corp. 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors
KR20180095564A (ko) 2015-12-22 2018-08-27 지앙수 헨그루이 메디슨 컴퍼니 리미티드 벤조피페리딘 유도체, 이의 제조 방법 및 이의 의학적 용도
US10736894B2 (en) 2018-02-15 2020-08-11 Ovid Therapeutics Inc. Methods of treating developmental syndromes with PDE10A inhibitors
CN108498868B (zh) * 2018-04-03 2020-09-15 北京大学口腔医学院 具有细胞外基质电学拓扑特征的带电复合膜及其制备方法
CN110407806B (zh) * 2018-04-28 2021-08-17 深圳微芯生物科技股份有限公司 甲酰胺类化合物、其制备方法及其应用
WO2019241787A1 (en) * 2018-06-15 2019-12-19 The Regents Of The University Of Colorado A Body Corporate Novel cyclic gmp-amp synthase (cgas) inhibitors and their method of use
EP3856185A1 (en) * 2018-09-28 2021-08-04 Takeda Pharmaceutical Company Limited Balipodect for treating or preventing autism spectrum disorders
MX2019008440A (es) 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.
EP3805206A1 (en) * 2019-10-08 2021-04-14 Novaled GmbH Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same
GB202002926D0 (en) 2020-02-28 2020-04-15 Benevolentai Tech Limited Compositions and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011693A1 (de) * 1978-10-03 1980-06-11 Ciba-Geigy Ag Neue N-(trifluormethansulfonylaminophenyl)-substituierte N-Heterocyclen, ihre Herstellung, sie enthaltende Mittel und ihre Verwendung zur Beeinflussung des Pflanzenwachstums
FR2648135B1 (fr) * 1989-06-07 1991-09-27 Pf Medicament Derives de phenyl-1-dihydro-1,4 amino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique
GB9506382D0 (en) * 1995-03-29 1995-05-17 Boots Co Plc Pharmaceutical compositions
EP1130015A4 (en) 1998-08-14 2006-02-08 Nihon Nohyaku Co Ltd PYRIDAZINONE DERIVATIVES
US20070060606A1 (en) 1999-10-07 2007-03-15 Robertson Harold A Compounds and methods for modulating phosphodiesterase 10A
GB0013383D0 (en) 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
AU2001296871A1 (en) 2000-09-15 2002-03-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7005432B2 (en) 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
CA2568929A1 (en) 2004-06-07 2005-12-22 Pfizer Products Inc. Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
RU2346996C2 (ru) 2004-06-29 2009-02-20 ЮРОПИЭН НИКЕЛЬ ПиЭлСи Усовершенствованное выщелачивание основных металлов
BRPI0518508A2 (pt) 2005-01-07 2008-11-25 Pfizer Prod Inc compostos de quinolina heteroaromÁticos e seu uso como inibidores de pde10
JP4890439B2 (ja) 2005-03-07 2012-03-07 杏林製薬株式会社 ピラゾロピリジン−4−イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするpde阻害剤
WO2008001182A1 (en) 2006-06-26 2008-01-03 Pfizer Products Inc. Tricyclic heteroaryl compounds as pde10 inhibitors
TW200801513A (en) 2006-06-29 2008-01-01 Fermiscan Australia Pty Ltd Improved process
US20080090834A1 (en) 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2010000020A1 (en) 2008-06-30 2010-01-07 Cathrx Ltd A catheter
TWI396689B (zh) 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物
AR074343A1 (es) 2008-11-14 2011-01-12 Amgen Inc Derivados de piridina y pirimidina como inhibidores de la fosfodiesterasa 10
JP5502890B2 (ja) * 2008-12-04 2014-05-28 エフ.ホフマン−ラ ロシュ アーゲー ピリダジノン誘導体
BRPI1008498B8 (pt) * 2009-02-05 2021-05-25 Takeda Pharmaceuticals Co compostos de piridazinona úteis como inibidores da fosfodiesterase 10a, composição farmacêutica, e, uso de um composto
US9187455B2 (en) 2009-02-23 2015-11-17 Hoffmann-La Roche Inc. Substituted pyridazines as PDE10A inhibitors
US8415381B2 (en) 2009-07-30 2013-04-09 Novartis Ag Heteroaryl compounds and their uses
WO2012018058A1 (ja) * 2010-08-04 2012-02-09 武田薬品工業株式会社 縮合複素環化合物
EP2604597B1 (en) * 2010-08-10 2017-01-04 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof inhibitor of phosphodiesterase 10a

Similar Documents

Publication Publication Date Title
JP2012516890A5 (enExample)
AU2016256728B2 (en) Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions
RU2757457C2 (ru) Пирролопиримидины в качестве потенциаторов мвтр
CA2836851C (en) Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
JP4101852B2 (ja) シンナミド化合物
CA2958490A1 (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives
JP3490716B2 (ja) 炎症治療用3,4−置換ピラゾール
DK2576543T3 (en) Pyrazole compounds as sigma receptor inhibitors
US9150588B2 (en) Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
EA012211B1 (ru) Гетероароматические соединения хинолинов и их применение в качестве ингибиторов pde10
JP2009500327A (ja) アミノ−5−(5員)ヘテロアリールイミダゾロン化合物およびβ−セレクターゼ調節のためのその使用
EA021359B1 (ru) N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме
CN103781768B (zh) Pde10调节剂
JPWO2015012400A1 (ja) グリシントランスポーター阻害物質
WO2008039023A1 (en) Heteroaryl-pyrazole derivatives as cannabinoid cb1 receptor antagonists
KR101842382B1 (ko) 모폴린-피리딘 유도체
JP4827821B2 (ja) シンナミド化合物
TW200944522A (en) 3-indazolyl-4-pyridylisothiazoles